quinine [Ligand Id: 2510] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL170 (NSC-192949, Quinine, WR297608)
  • ABCB1/P-glycoprotein 1 in Human [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183]
  • This target only has 1 pki data point
  • 4.92
1 CHEMBL170_lig_chart_1 P-glycoprotein 1 Human
There should be some charts here, you may need to enable JavaScript!
  • Plasmodium falciparum [ChEMBL: CHEMBL364]
  • This target only has 0 pki data point
  • 0
2 CHEMBL170_lig_chart_2 Plasmodium falciparum Plasmodium falciparum
There should be some charts here, you may need to enable JavaScript!
  • Plasmodium falciparum 3D7 [ChEMBL: CHEMBL2366922]
  • This target only has 0 pki data point
  • 0
3 CHEMBL170_lig_chart_3 Plasmodium falciparum 3D7 Plasmodium falciparum 3D7
There should be some charts here, you may need to enable JavaScript!
  • Plasmodium falciparum (isolate K1 / Thailand) in Plasmodium falciparum K1 [ChEMBL: CHEMBL612856]
  • This target only has 0 pki data point
  • 0
4 CHEMBL170_lig_chart_4 Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1
There should be some charts here, you may need to enable JavaScript!
  • Organic cation transporter 1/Solute carrier family 22 member 1 in Human [ChEMBL: CHEMBL5685] [GtoPdb: 1019] [UniProtKB: O15245]
  • Organic cation transporter 1/Solute carrier family 22 member 1 in Mouse [ChEMBL: CHEMBL2073664] [GtoPdb: 1019] [UniProtKB: O08966]
  • Organic cation transporter 1/Solute carrier family 22 member 1 in Rat [ChEMBL: CHEMBL2073670] [GtoPdb: 1019] [UniProtKB: Q63089]
  • 5.7
5 CHEMBL170_lig_chart_5 Solute carrier family 22 member 1 HumanMouseRat
There should be some charts here, you may need to enable JavaScript!
  • Organic cation transporter 2/Solute carrier family 22 member 2 in Human [ChEMBL: CHEMBL1743122] [GtoPdb: 1020] [UniProtKB: O15244]
  • Organic cation transporter 2/Solute carrier family 22 member 2 in Mouse [ChEMBL: CHEMBL2073662] [GtoPdb: 1020] [UniProtKB: O70577]
  • Organic cation transporter 2/Solute carrier family 22 member 2 in Rat [ChEMBL: CHEMBL1770032] [GtoPdb: 1020] [UniProtKB: Q9R0W2]
  • 4.26
6 CHEMBL170_lig_chart_6 Solute carrier family 22 member 2 HumanMouseRat
There should be some charts here, you may need to enable JavaScript!
  • Solute carrier organic anion transporter family member 1A1 in Rat [ChEMBL: CHEMBL1781859] [UniProtKB: P46720]
  • This target only has 1 pki data point
  • 4.12
7 CHEMBL170_lig_chart_7 Solute carrier organic anion transporter family member 1A1 Rat
There should be some charts here, you may need to enable JavaScript!
  • Solute carrier organic anion transporter family member 1A4 in Rat [ChEMBL: CHEMBL1781860] [UniProtKB: O35913]
  • This target only has 1 pki data point
  • 5.42
8 CHEMBL170_lig_chart_8 Solute carrier organic anion transporter family member 1A4 Rat
There should be some charts here, you may need to enable JavaScript!
  • Kv2.2 in Human [GtoPdb: 547] [UniProtKB: Q92953]
  • This target only has 0 pki data point
  • 0
9 CHEMBL170_lig_chart_9 Kv2.2 Human
There should be some charts here, you may need to enable JavaScript!
  • Plasma membrane monoamine transporter in Human [GtoPdb: 1120] [UniProtKB: Q7RTT9]
  • This target only has 1 pki data point
  • 4.57
10 CHEMBL170_lig_chart_10 Plasma membrane monoamine transporter Human
There should be some charts here, you may need to enable JavaScript!
  • Plasmodium falciparum purine nucleoside phosphorylase in Plasmodium falciparum [GtoPdb: 3077]
  • This target only has 1 pki data point
  • 6.86
11 CHEMBL170_lig_chart_11 Plasmodium falciparum purine nucleoside phosphorylase Plasmodium falciparum
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183]
ChEMBL High affinity constant at binding site of human P-Glycoprotein (P-gp) in two-affinity model B 4.92 pKi 12000 nM Ki J. Med. Chem. (2002) 45: 5671-5686 [PMID:12477351]
ChEMBL TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in NIH-3T3-G185 cells F 4.06 pIC50 87600 nM IC50 Biochem. Biophys. Res. Commun. (2001) 289: 580-585 [PMID:11716514]
ChEMBL TP_TRANSPORTER: inhibition of LDS-751 efflux in NIH-3T3-G185 cells F 4.13 pIC50 74400 nM IC50 Biochem. Biophys. Res. Commun. (2001) 289: 580-585 [PMID:11716514]
ChEMBL TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells F 4.65 pIC50 22600 nM IC50 Biochem. Biophys. Res. Commun. (2001) 289: 580-585 [PMID:11716514]
ChEMBL Inhibition of P-gp-mediated Rhodamine-123 efflux in human MCF-7/DOX cells assessed as Rhodamine-123 accumulation preincubated for 15 mins followed by Rhodamine-123 addition measured after 0.5 to 4 hrs by fluorescence assay B 5.77 pIC50 1700 nM IC50 Eur J Med Chem (2019) 176: 268-291 [PMID:31103904]
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL Antimicrobial activity against Plasmodium falciparum F 4.27 pIC50 54000 nM IC50 Bioorg. Med. Chem. (2010) 18: 2225-2231 [PMID:20185316]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N40 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 5.67 pIC50 2123 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT K14 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 5.88 pIC50 1310 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09A41 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 5.89 pIC50 1295 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B61 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 5.95 pIC50 1128 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B7 harboring pfnhe1 ms4760 haplotype 9 carrying 3 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 5.96 pIC50 1099 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against schizont stage of atovaquone-resistant Plasmodium falciparum Tm90C2b infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis F 5.97 pIC50 1068 nM IC50 MedChemComm (2011) 2: 430-435
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT 9996 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 5.98 pIC50 1039 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT K4 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 5.99 pIC50 1034 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B2 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 5.99 pIC50 1016 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum IMT K14 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.01 pIC50 969 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimalarial activity against Plasmodium falciparum IMT K4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.02 pIC50 953 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimalarial activity against schizont stage of chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis F 6.04 pIC50 917 nM IC50 MedChemComm (2011) 2: 430-435
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N35 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.04 pIC50 905 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-46 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.05 pIC50 894 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B41 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.05 pIC50 886 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-3 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.06 pIC50 875 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-8 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042D 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.06 pIC50 874 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B27 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.06 pIC50 870 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N29 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042D 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.07 pIC50 853 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum harboring pfnhe1 ms4760 haplotype 9 carrying 3 copies of DNNND repeat and His/Asp ratio 7:6 infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.08 pIC50 837 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum after 48 hrs F 6.08 pIC50 826 nM IC50 Eur. J. Med. Chem. (2016) 112: 270-279 [PMID:26900659]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-35 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.09 pIC50 821 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum harboring pfnhe1 ms4760 haplotype 14 carrying 3 copies of DNNND repeat and His/Asp ratio 6:6 infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.12 pIC50 767 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B60 harboring pfnhe1 ms4760 haplotype 14 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.12 pIC50 767 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum ms4760-7 assessed as growth inhibition after 48 hrs by scintillation counting F 6.12 pIC50 764 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum W2 harboring pfnhe1 ms4760 haplotype 1 carrying 2 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86Y 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.14 pIC50 720 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09A10 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.15 pIC50 716 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N66 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.15 pIC50 711 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N6 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042D 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.15 pIC50 710 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Bres infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.16 pIC50 688.7 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum W2 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.16 pIC50 686 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum W2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.17 pIC50 683.9 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-58 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.17 pIC50 680 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum W2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.17 pIC50 670 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCR3 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.18 pIC50 665.3 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND repeat and His/Asp ratio 5:6 infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.18 pIC50 661 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-27 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.19 pIC50 650 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum FCR3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.19 pIC50 650 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-11 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.2 pIC50 629 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum PA infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.2 pIC50 626.6 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum PA harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.2 pIC50 625 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.21 pIC50 619.4 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum 7G8 harboring pfnhe1 ms4760 haplotype 1 carrying 2 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034C 1042D 1246Y and pfcrt 72-76 SVMNT 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.21 pIC50 619 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against schizont stage of atovaquone-resistant Plasmodium falciparum Tm90C2b infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis F 6.22 pIC50 608 nM IC50 MedChemComm (2011) 2: 430-435
ChEMBL Antimalarial activity against Plasmodium falciparum IMT K2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.22 pIC50 607 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT A4 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.22 pIC50 605 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimalarial activity against Plasmodium falciparum IMT Bres assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.22 pIC50 604 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimicrobial activity against Plasmodium falciparum Dd2 harboring pfnhe1 ms4760 haplotype 1 carrying 2 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86Y 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.22 pIC50 602 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT K2 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.22 pIC50 599 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B72 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.23 pIC50 583 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against schizont stage of chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis F 6.23 pIC50 583 nM IC50 MedChemComm (2011) 2: 430-435
ChEMBL Antimicrobial activity against Plasmodium falciparum ms4760-6 assessed as growth inhibition after 48 hrs by scintillation counting F 6.24 pIC50 582 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND repeat and His/Asp ratio 5:4 infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.24 pIC50 580 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum FCM29 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.24 pIC50 580 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B63 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.24 pIC50 579 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT L1 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.24 pIC50 575 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-34 harboring pfnhe1 ms4760 haplotype 9 carrying 3 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.24 pIC50 574 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum PA assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.24 pIC50 571 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PA infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay F 6.24 pIC50 571 nM IC50 J. Med. Chem. (2009) 52: 7954-7957 [PMID:19908867]
ChEMBL Antimalarial activity against Plasmodium falciparum isolate AK127 F 6.24 pIC50 569.5 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3302-3307 [PMID:20516285]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09A9 harboring pfnhe1 ms4760 haplotype 5 carrying 4 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.25 pIC50 562 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum isolate AK182 F 6.26 pIC50 549.2 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3302-3307 [PMID:20516285]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCM29 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.26 pIC50 543.3 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-6 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.27 pIC50 543 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum IMT L1 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.27 pIC50 543 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTL1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay F 6.27 pIC50 543 nM IC50 J. Med. Chem. (2009) 52: 7954-7957 [PMID:19908867]
ChEMBL Antimalarial activity against Plasmodium falciparum IMT A4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.27 pIC50 543 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimalarial activity against Plasmodium falciparum FCM29 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.27 pIC50 538 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N22 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.27 pIC50 535 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum L1 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.27 pIC50 530.9 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N44 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.29 pIC50 514 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N78 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.29 pIC50 513 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-25 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.3 pIC50 502 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT Bres harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.3 pIC50 500 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N72 harboring pfnhe1 ms4760 haplotype 5 carrying 4 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.3 pIC50 500 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K14 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.3 pIC50 495.5 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimalarial activity against Plasmodium falciparum isolate AK227 F 6.31 pIC50 495.3 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3302-3307 [PMID:20516285]
ChEMBL Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum W2 by ELISA F 6.31 pIC50 490.8 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 1200-1206 [PMID:20065051]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N33 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.31 pIC50 490 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N64 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.32 pIC50 475 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-28 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.33 pIC50 473 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F08B53 harboring pfnhe1 ms4760 haplotype 1 carrying 2 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.33 pIC50 468 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum harboring pfnhe1 ms4760 haplotypes 5,34 carrying4 copies of DNNND repeat and His/Asp ratio 5:8 infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.34 pIC50 462 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-7 harboring pfnhe1 ms4760 haplotype 1 carrying 2 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.34 pIC50 456 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT 6311 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.34 pIC50 453 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09N58 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.35 pIC50 448 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-23 harboring pfnhe1 ms4760 haplotype 1 carrying 2 copies of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.35 pIC50 447 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-31 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.36 pIC50 433 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antiplasmodial activity against chloroquine/mefloquine-resistant Plasmodium falciparum SRIV35 F 6.37 pIC50 431 nM IC50 Eur. J. Med. Chem. (2015) 94: 56-62 [PMID:25747499]
ChEMBL Antimalarial activity against Plasmodium falciparum IMT Vol assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.37 pIC50 428 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTVo1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay F 6.37 pIC50 428 nM IC50 J. Med. Chem. (2009) 52: 7954-7957 [PMID:19908867]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-56 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.37 pIC50 427 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Voll infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs F 6.37 pIC50 421.7 nM IC50 J. Med. Chem. (2010) 53: 3214-3226 [PMID:20329733]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT Vol harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.38 pIC50 421 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 Indochina by [3H]hypoxanthine uptake F 6.38 pIC50 413 nM IC50 J. Nat. Prod. (2001) 64: 12-16 [PMID:11170658]
ChEMBL Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2/Indochina by [3H]hypoxanthine uptake F 6.38 pIC50 413 nM IC50 J. Nat. Prod. (2002) 65: 1381-1386 [PMID:12398531]
ChEMBL Antimicrobial activity against Plasmodium falciparum K1 harboring pfnhe1 ms4760 haplotype 5 carrying 4 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86Y 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.39 pIC50 407 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-42 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.41 pIC50 388 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Inhibitory concentration against multidrug-resistant Plasmodium falciparum Dd2. F 6.42 pIC50 380 nM IC50 Bioorg. Med. Chem. Lett. (2002) 12: 2681-2683 [PMID:12217353]
ChEMBL Inhibition against Plasmodium falciparum Dd2 in erythrocytes in semiautomated micro dilution assay F 6.42 pIC50 380 nM IC50 Bioorg. Med. Chem. Lett. (2003) 13: 2159-2161 [PMID:12798326]
ChEMBL Antimalarial activity against Plasmodium falciparum Dd2 in erythrocytes F 6.42 pIC50 380 nM IC50 Bioorg. Med. Chem. Lett. (2002) 12: 543-545 [PMID:11844668]
ChEMBL Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes F 6.42 pIC50 380 nM IC50 Bioorg. Med. Chem. Lett. (2001) 11: 423-424 [PMID:11212126]
ChEMBL Antimicrobial activity against Plasmodium falciparum F09A61 harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.43 pIC50 373 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum Feng harboring pfnhe1 ms4760 haplotype 7 carrying 3 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.43 pIC50 371 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum IMT 31 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.43 pIC50 371 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL In vitro antimalarial activity against Plasmodium falciparum W2 in human erythrocytes by [3H]hypoxanthine uptake F 6.43 pIC50 370 nM IC50 Bioorg. Med. Chem. Lett. (2002) 12: 1351-1355 [PMID:11992775]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-13 harboring pfnhe1 ms4760 haplotype 3 carrying 1 copy of DNNND and 2 copies of NHNDNHNNDDD repeats, pfmdr1 86N 184Y 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.44 pIC50 365 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimicrobial activity against Plasmodium falciparum FCR3 harboring Pfcrt, Pfmdr1, Pfmrp, and Pfnhe-1 polymorphisms assessed as growth inhibition after 48 hrs by scintillation counting F 6.48 pIC50 334 nM IC50 Antimicrob. Agents Chemother. (2009) 53: 1926-1930 [PMID:19273668]
ChEMBL Antimalarial activity against Plasmodium falciparum isolate CDA-1553 F 6.48 pIC50 333.3 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3302-3307 [PMID:20516285]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-47 harboring pfnhe1 ms4760 haplotype 20 carrying 4 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.49 pIC50 324 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against Plasmodium falciparum IMT Guy assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter F 6.49 pIC50 322 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 3537-3544 [PMID:20547801]
ChEMBL Antimicrobial activity against Plasmodium falciparum F07-9 harboring pfnhe1 ms4760 haplotype 6 carrying 2 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042N 1246D and pfcrt 72-76 CVIET 220S infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.49 pIC50 321 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against chloroquine resistant Plasmodium falciparum Dd2 after 72 hrs by SYBP Green I dye staining F 6.49 pIC50 320 nM IC50 Bioorg. Med. Chem. (2012) 20: 3292-3297 [PMID:22512909]
ChEMBL Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by 1536-well format based SYBR green assay F 6.49 pIC50 320 nM IC50 Nat. Chem. Biol. (2009) 5: 765-771 [PMID:19734910]
ChEMBL Antimicrobial activity against Plasmodium falciparum HB3 harboring pfnhe1 ms4760 haplotype 5 carrying 4 copies of DNNND and 1 copy of NHNDNHNNDDD repeats, pfmdr1 86N 184F 1034S 1042D 1246D and pfcrt 72-76 CVMNK 220A infected in human erythrocytes after 72 hrs by SYBR green I-based fluorescence assay F 6.5 pIC50 319 nM IC50 Antimicrob. Agents Chemother. (2010) 54: 4306-4313 [PMID:20643902]
ChEMBL Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT10500 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay F 6.5 pIC50 314 nM